Literature DB >> 10508815

Exercise rehabilitation and chronic obstructive pulmonary disease stage.

M J Berry1, W J Rejeski, N E Adair, D Zaccaro.   

Abstract

To determine the extent to which patients with Stage I COPD experience improvements in physical performance and quality of life as a result of exercise training, and to compare these improvements with those seen in Stage I and II patients, 151 patients with COPD underwent a 12-wk exercise program. Outcomes were measured at baseline and follow-up. Physical performance was evaluated by means of a 6-min walk, treadmill time, an overhead task, and a stair climb. General health-related quality of life was assessed in terms of the domains of Social Function, Health Perceptions, and Life Satisfaction. Disease-specific health-related quality of life was assessed with the Chronic Respiratory Disease Questionnaire (CRQ). Six-minute walk distance increased significantly in Stage I (200.5 ft [95% CI: 165.4, 235.7]), Stage II (238.3 ft [143.3, 333.3]), and Stage III (112.1 ft [34.6, 189.6]) participants. Treadmill time increased significantly in Stage I (0.42 min [0.20, 0.64]) and Stage II (0.64 min [0.14, 1.4]) participants. Time to complete the overhead task decreased significantly in Stage I (0.91 s [1.72, 0. 11]) and Stage II (1.39 s [2.66, 0.13]) participants. None of the measures of general health-related quality of life improved in any of the three groups. Participants in Stages I, II, and III all experienced improvements in the CRQ domains of dyspnea (0.72 [0.53, 0.91], 0.47 [0.02, 0.91], and 0.46 [0.05, 0.87], respectively) and fatigue (0.49 [0.33, 0.66], 0.54 [0.20, 0.87], and 0.55 [0.05, 1.05], respectively). These results suggest that all patients with COPD will benefit from exercise rehabilitation. Berry MJ, Rejeski WJ, Adair NE, Zaccaro D. Exercise rehabilitation and chronic obstructive pulmonary disease stage.

Entities:  

Mesh:

Year:  1999        PMID: 10508815     DOI: 10.1164/ajrccm.160.4.9901014

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  37 in total

Review 1.  Pulmonary rehabilitation.

Authors: 
Journal:  Thorax       Date:  2001-11       Impact factor: 9.139

2.  The new contract: renaissance or requiem for general practice?

Authors:  Martin Marshall; Martin Roland
Journal:  Br J Gen Pract       Date:  2002-07       Impact factor: 5.386

3.  Barriers to adherence to COPD guidelines among primary care providers.

Authors:  Xavier Perez; Juan P Wisnivesky; Linda Lurslurchachai; Lawrence C Kleinman; Ian M Kronish
Journal:  Respir Med       Date:  2011-10-13       Impact factor: 3.415

Review 4.  Issues in selecting outcome measures to assess functional recovery after stroke.

Authors:  Sharon Barak; Pamela W Duncan
Journal:  NeuroRx       Date:  2006-10

5.  Measuring disability in older adults: the International Classification System of Functioning, Disability and Health (ICF) framework.

Authors:  W Jack Rejeski; Edward H Ip; Anthony P Marsh; Michael E Miller; Deborah F Farmer
Journal:  Geriatr Gerontol Int       Date:  2008-03       Impact factor: 2.730

6.  Comparison of Effects of Endurance and Strength Training Programs in Patients with COPD.

Authors:  Michael J Berry; Katherine L Sheilds; Norman E Adair
Journal:  COPD       Date:  2018-04-16       Impact factor: 2.409

7.  Clinician's Commentary.

Authors:  Gail Dechman
Journal:  Physiother Can       Date:  2010-10-18       Impact factor: 1.037

8.  Pulmonary Rehabilitation Improves Outcomes in Chronic Obstructive Pulmonary Disease Independent of Disease Burden.

Authors:  Praful Schroff; Jason Hitchcock; Christopher Schumann; J Michael Wells; Mark T Dransfield; Surya P Bhatt
Journal:  Ann Am Thorac Soc       Date:  2017-01

Review 9.  Effects of resistance training on respiratory function in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  Barbara Strasser; Uwe Siebert; Wolfgang Schobersberger
Journal:  Sleep Breath       Date:  2012-03-07       Impact factor: 2.816

Review 10.  Should mild COPD be treated? Evidence for early pharmacological intervention.

Authors:  Amany F Elbehairy; Katherine A Webb; J Alberto Neder; J Alberto Neder; Denis E O'Donnell
Journal:  Drugs       Date:  2013-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.